Project Grant K23DA062172
Award Date 2/15/26
Completion Date 1/31/31
Dollars Obligated $195K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10029, USA
Similar Awards
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Johns Hopkins University a Project Grant totaling $193,854 under the Drug Use and Addiction Research Programs (CFDA 93.279) for the period September 1, 2025, through August 31, 2027. The award funds an epidemiological cohort study examining the association between xylazine use and adverse health outcomes among people who have injected drugs in the Baltimore area. The study will leverage the existing ALIVE...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $196,020 Project Grant (K23 career development award) to the University of Pennsylvania effective September 1, 2025, through August 31, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279). The award supports Dr. Eleanor Turi, PhD, RN, CCRN in conducting mentored research training to identify low-barrier wound care models associated with positive patient outcomes among people who inject drugs...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Scripps Research Institute a $506,000 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning July 15, 2025, through June 30, 2027. The award supports research focused on the preparation and investigation of monoclonal antibodies designed to block xylazine's mechanism of action and mitigate its adverse effects. Xylazine, a veterinary sedative increasingly detected as an adulterant...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded a $159,615 Project Grant to Icahn School of Medicine at Mount Sinai on July 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant supports research titled "Predicting Craving and Relapse Using Neurobehavioral Markers of Goals and Habits in Opioid Use Disorder," which addresses the critical public health challenge of opioid overdose deaths exceeding 100,000 annually in 2022. The...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $388,222 to Icahn School of Medicine at Mount Sinai on August 1, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support a K23 Career Development Award. This five-year project, extending through July 31, 2030, funds the development and pilot testing of the Pediatric Emergency Department-Initiated Support Program to Link Care (PEDS-TLC), a comprehensive intervention designed to...
- Federal Grant Award Summary Thomas Jefferson University, operating as Sidney Kimmel Medical College, received a $346,500 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning February 15, 2026, with a completion date of January 31, 2028. The award supports research addressing the intersection of xylazine contamination in the opioid supply and pregnancy outcomes for women who use opioids (PWUO). The project...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Washington University a Project Grant totaling $466,500.00 under the Drug Use and Addiction Research Programs (CFDA 93.279) effective June 15, 2025, with a completion date of May 31, 2027. This research project addresses the emerging public health threat of xylazine contamination in the illicit drug supply and associated invasive infections. The primary deliverables include active surveillance of the local...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a Mentored Research Scientist Development Award (K01) totaling $399,600 under the Drug Use and Addiction Research Programs (CFDA 93.279) to support a five-year career development and mentored research initiative. Awarded on August 15, 2025, with completion targeted for July 31, 2030, this grant funds Dr. Jason Brian Gibbons at the University of Colorado Anschutz Medical Campus to develop machine learning-based...
- Federal Grant Award Summary Yale University received a $197,024 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) effective July 30, 2025, through June 30, 2027. This award supports a two-state research initiative examining the impact of xylazine, a veterinary tranquilizer increasingly present in the unregulated opioid supply, on people who use drugs (PWUD). The project delivers comprehensive research services...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Pittsburgh $493,454 under the Drug Use and Addiction Research Programs (CFDA 93.279) for a two-year project period (September 1, 2025 – August 31, 2027) to conduct research on the effects of xylazine exposure on maternal, perinatal, and infant outcomes. The research addresses a critical public health issue, as overdose deaths among pregnant women who use drugs (PWWUD) account for...